Filing Details
- Accession Number:
- 0001104659-25-062224
- Form Type:
- 13G Filing
- Publication Date:
- 2025-06-23 20:00:00
- Filed By:
- FOG Ventures Investments, LLC
- Company:
- Oncology Institute Inc.
- Filing Date:
- 2025-06-24
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
|---|---|---|---|
| FOG Ventures Investments, LLC | 0 | 0 | 0% |
| Daniel Murillo | 0 | 0 | 0% |
Filing
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)
|
Oncology Institute, Inc. (Name of Issuer) |
Common Stock, par value $0.0001 per share (Title of Class of Securities) |
68236X100 (CUSIP Number) |
05/15/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
 Rule 13d-1(c)
|
| Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 68236X100 |
| 1 | Names of Reporting Persons
FOG Ventures Investments, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
OO |
Comment for Type of Reporting Person: This Amendment No. 1 to Schedule 13G is filed to amend the Schedule 13G filed by the Reporting Persons named therein on November 24, 2021. This Amendment No. 1 constitutes an "exit filing" for the Reporting Persons.
SCHEDULE 13G
|
| CUSIP No. | 68236X100 |
| 1 | Names of Reporting Persons
Daniel Murillo | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: Daniel Murillo is the sole managing member of FOG Venture Investments, LLC and has voting and dispositive control over any shares it holds .
SCHEDULE 13G
|
| Item 1. | |
| (a) | Name of issuer:
Oncology Institute, Inc. |
| (b) | Address of issuer's principal executive offices:
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703 |
| Item 2. | |
| (a) | Name of person filing:
FOG Venture Investments, LLC
Daniel Murillo |
| (b) | Address or principal business office or, if none, residence:
The address of the principal business office for each of the Reporting Persons is: 3270 Firestone Blvd, Ste 740, South Gate, CA 90280 |
| (c) | Citizenship:
See Row 4 of each Reporting Person's cover page to this Schedule 13G. |
| (d) | Title of class of securities:
Common Stock, par value $0.0001 per share |
| (e) | CUSIP No.:
68236X100 |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
See Row 9 of each Reporting Person's cover page to this Schedule 13G. |
| (b) | Percent of class:
See Row 11 of each Reporting Person's cover page to this Schedule 13G. |
| (c) | Number of shares as to which the person has:
|
| (i) Sole power to vote or to direct the vote:
See Row 5 of each Reporting Person's cover page to this Schedule 13G. | |
| (ii) Shared power to vote or to direct the vote:
See Row 6 of each Reporting Person's cover page to this Schedule 13G. | |
| (iii) Sole power to dispose or to direct the disposition of:
See Row 7 of each Reporting Person's cover page to this Schedule 13G. | |
| (iv) Shared power to dispose or to direct the disposition of:
See Row 8 of each Reporting Person's cover page to this Schedule 13G. | |
| Item 5. | Ownership of 5 Percent or Less of a Class. |
|
Ownership of 5 percent or less of a class
| |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
Not Applicable
| |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable
| |
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable
| |
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
|
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|